BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8695161)

  • 41. Primary stage I-IIE non-Hodgkin's lymphoma of uterine cervix and upper vagina: evidence for a conservative approach in a study on three patients.
    Garavaglia E; Taccagni G; Montoli S; Panacci N; Ponzoni M; Frigerio L; Mangili G
    Gynecol Oncol; 2005 Apr; 97(1):214-8. PubMed ID: 15790461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of primary thyroid non-Hodgkin's lymphoma: a series of nine consecutive cases.
    Colović M; Matić S; Kryeziu E; Tomin D; Colović N; Atkinson HD
    Med Oncol; 2007; 24(2):203-8. PubMed ID: 17848745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy.
    Krol AD; Berenschot HW; Doekharan D; Henzen-Logmans S; van der Holt B; van 't Veer MB
    Radiother Oncol; 2001 Mar; 58(3):251-5. PubMed ID: 11230885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of feline lymphoma using a 12-week, maintenance-free combination chemotherapy protocol in 26 cats.
    Limmer S; Eberle N; Nerschbach V; Nolte I; Betz D
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1():21-31. PubMed ID: 24548273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
    Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y
    Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thyroid lymphomas stages IE and IIE: comparative results for radiotherapy only, combination chemotherapy only, and multimodality treatment.
    Vigliotti A; Kong JS; Fuller LM; Velasquez WS
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1807-12. PubMed ID: 2428787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
    Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
    J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of non-Hodgkin's lymphoma of the thyroid: the Royal Marsden Hospital experience.
    Harrington KJ; Michalaki VJ; Vini L; Nutting CM; Syrigos KN; A'hern R; Harmer CL
    Br J Radiol; 2005 May; 78(929):405-10. PubMed ID: 15845932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease.
    Gustavsson A
    Acta Oncol; 1997; 36(5):483-8. PubMed ID: 9292744
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].
    Hoederath A; Sack H; Stuschke M; Lampka E
    Strahlenther Onkol; 1996 Jul; 172(7):356-66; discussion 367-8. PubMed ID: 8693402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiotherapy in early stage gastrointestinal lymphoma: results of the German GIT-NHL group.
    Willich NA; Reinartz G; Reers B; Hiddemann W; Tiemann M; Parwaresch R; Grothaus-Pinke B; Kocik J; Koch P;
    Ann Hematol; 2001; 80 Suppl 3():B97-9. PubMed ID: 11757719
    [No Abstract]   [Full Text] [Related]  

  • 52. [Prognostic factors of invasive non-Hodgkin's lymphoma].
    Yu H; Hong XN; Li J; Peng LP; Ye L
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):461-3. PubMed ID: 17974284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A case of primary malignant lymphoma of the prostate presenting as urinary retention].
    Kinouchi T; Kinoshita T; Kobayashi M; Ueda T; Inoue H; Takada T; Hara T
    Hinyokika Kiyo; 2010 Oct; 56(10):589-92. PubMed ID: 21063166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prospective study of reduced-dose three-course CHOP followed by involved-field radiotherapy for patients 70 years old or more with localized aggressive non-Hodgkin's lymphoma.
    Shikama N; Oguchi M; Isobe K; Nakamura K; Tamaki Y; Hasegawa M; Kodaira T; Sasaki S; Kagami Y;
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):217-22. PubMed ID: 16814951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Malignant lymphoma of the thyroid].
    Ohye H; Fukata S; Hirokawa M
    Nihon Rinsho; 2007 Nov; 65(11):2092-8. PubMed ID: 18018576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A cyclophosphamide-induced autoimmune diabetes.
    Atlan-Gepner C; Bouabdallah R; Valero R; Coso D; Vialettes B
    Lancet; 1998 Aug; 352(9125):373-4. PubMed ID: 9717935
    [No Abstract]   [Full Text] [Related]  

  • 57. Primary non-Hodgkin's lymphoma of the thyroid with bone marrow infiltration at presentation.
    Evans TR; Mansi JL; Bevan DH; Dalgleish AG; Harmer CL
    Clin Oncol (R Coll Radiol); 1995; 7(1):54-5. PubMed ID: 7727310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Non-Hodgkin's lymphoma of the parotid gland].
    Kempf HG
    HNO; 1990 May; 38(5):166-9. PubMed ID: 2373642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.